Prices of medicines

Prices of medicines : “It is not feasible to discourage industrial investment “


If it were not for the case of the Lévothyrox – this product including the change of the generic would be responsible for an epidemic of side effects – one might almost think that the drugs do not pose more than money problems.

Industrial companies have long justified their high prices by two arguments : the costs of research and development (R.

Leave a Reply

Your email address will not be published.